Licensed dosing of stimulants is associated with more reduced symptoms in adults with ADHD than unlicensed dosing, according to a new systematic review meta-analysis led by Luis C. Farhat, MD, of University Hospital in São Paulo, Brazil.[1]

New research from the NIH’s Environmental influences on Child Health Outcomes (ECHO) Program suggests that during the COVID-19 pandemic, some teens with a history of depression, anxiety, autism and ADHD experienced more severe impacts than those without.

On October 30, 2023, Otsuka Pharmaceutical announced positive results from 2 pivotal phase 3 trials of centanafadine, a norepinephrine, dopamine, and serotonin reuptake inhibitor, for adolescents and children with Attention-Deficit/Hyperactivity Disorder (ADHD).[1]

A recent study has found that the link between low fetal growth rate and symptoms of attention-deficit/hyperactivity disorder (ADHD) in children can partially be explained by factors occurring before birth such as pregnancy complications, in addition to familial characteristics such as household income. The findings were published in Research on Child and Adolescent Psychopathology.

Children and young people with attention deficit hyperactivity disorder (ADHD) use health care services twice as often in the two years before their diagnosis, a study by researchers at the University of Nottingham and King’s College London has found.

Extended-release (ER) viloxazine demonstrates continued safety and efficacy with long-term use for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents, according to results presented at the American Academy of Child and Adolescent Psychiatry (AACAP) 2023 Annual Meeting, held from October 23 to 28, 2023 in New York, New York.

Both methylphenidate and atomoxetine improve motor coordination in children with attention-deficit/hyperactivity disorder (ADHD), according to new data presented at the American Academy of Child and Adolescent Psychiatry (AACAP) 2023 Annual Meeting, held from October 23 to 28, 2023 in New York, New York. However, the efficacy of these two medications varies across behavioral and emotional…

Several new genes associated with conditions such as Attention-deficit hyperactivity disorder (ADHD) have been identified, unearthing a significant connection between these disorders and our immune system that could lead to new treatments. The research from the University of Surrey, now published in Translational Psychiatry, also confirms the role of gene ADGRL3 in conditions such as ADHD, giving scientists…

William Ellerbe Pelham Jr., founding director of Florida International University’s Center for Children and Families, broke ground in the field of child and adolescent psychology for nearly five decades.

Summary: Youngest children in their class with ADHD are just as likely to keep the diagnosis when enter adulthood as older pupils in their year group. In the past, scientists have questioned the validity of ADHD in younger pupils, arguing they are only diagnosed because they are less mature than their peers. But this study…

Journaling can help you gain clarity, manage tasks better, and live a more organized life with ADHD. Here are some tips to get started.

How parents can help teens with ADHD overcome executive function challenges and succeed in school.